Stevanato Group

Activities: Pharmaceutical

Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries. Stevanato Group delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle at each of the development, clinical, and commercial stages.
Stevanato Group counts more than 5,600 people in 16 sites in 9 countries.

Visit website

Profile

Advanced Drug Containment Solutions & Analytical Services

Stevanato Group boasts unique expertise in providing advanced pharmaceutical containers from glass tubing. Its comprehensive portfolio covers every customer need, from those related to small molecules to highly sensitive drugs. Stevanato Group produces vials, syringes, and cartridges for different applications, such as vaccines, diabetes care, anesthetics, hormones, anticoagulants, and biologics. Glass containers are available both in bulk and in EZ-fill®, the market-recognized ready-to-use configuration. Stevanato Group can also provide container closure and device characterization analytical services through its Technology Excellence Centers.

Stevanato Group

Vision Inspection, Assembly & Packaging Technologies: A Modular & Flexible Approach

Stevanato Group's capabilities range from modular assembly platforms and packaging lines to advanced vision inspection machines, including manual, semi-automatic, and automatic. Stevanato Group equipment can inspect a wide range of liquid, emulsions, viscous, gel-like, powder, and lyophilized drugs, catering to the needs of both small firms and big pharma companies producing blockbuster drugs.

Trending Articles

  1. Scleroderma treatment by Certa Therapeutics granted US FDA fast track FT011 is a novel, first-in-class oral therapy for the treatment of chronic fibrosis in multiple organs
  2. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  3. Indian government bans three medicines owing to health risks Decision follows strong stand on suspending marketing of all drugs prohibited for sale in other countries, including the US, UK, EU and Australia
  4. Dickson achieves ISO 14001 certification ISO 14001 certification highlights a companies' long-term efforts to manage its environmental impact
  5. The key role of IVDs in healthcare: challenges to commercialisation and access In simple terms, in vitro diagnostic (IVD) tests are done on samples such as blood or tissue that have been taken from the human body. IVDs can detect diseases, conditions and...

Upcoming event

Interphex

16-18 April 2024 | Conference and Exhibition | New York, US See all

Related Content

Manufacturing

Quantoom collaborates with Stevanato to elevate mRNA production

The two companies have entered into a collaboration to promote and democratise access to mRNA production technologies worldwide by launching Quantoom's Nfinity platform
Distribution

DWK enters into distribution agreement with drug containment specialist Stevanato

The collaboration will leverage DWK Life Sciences experience in supplying a global network of laboratories and biopharma customers to broaden the distribution of RTU products
Drug Delivery

Expanding capacity through collaboration

Michael Earl, Director of Pharmaceutical Services at Owen Mumford, and Steven Kaufman, Vice President for Drug Delivery Systems, Stevanato Group, talk to Dr Kevin Robinson about their new partnership
Manufacturing

Industry first experiments break the mould for the VHP decontamination of RTU vials

Markus Heinz, Product Manager, Vial Liquid and Powder at Syntegon, and Fabio Bertacchini, Product Management Director at Stevanato Group, present new possibilities for small batch manufacturing
Distribution

Manufacturing Chemist LIVE 2022 in review (part II)

Taking a front row seat during the two-day pharmaceutical conference in Birmingham, UK, Dr Kevin Robinson reports on what’s new, emerging and exciting in the world of drug delivery and beyond
Digital

Artificial intelligence in the pharmaceutical industry

How can AI contribute to a positive return on investment for your inspection equipment?
Manufacturing

Steriline, Araymond and Stevanato Group together for a combined solution for laboratory batches

An all-in-one closure system for a superior quality in drugs primary packaging to enhance patient safety
Subscribe now